Improving the quality of healthcare
  • Twitter
  • Facebook
  • flickr
  • 020 7251 9060

National Confidential Enquiry into Patient Outcome and Death
MENU
  • Home
  • About
    • What we do
    • Impact
    • Medical Surgical
    • Child Health
    • Patients & Public
    • NCEPOD Team
    • NCEPOD Trustees
    • NCEPOD Steering Group
    • Topic submission
    • Vacancies
    • Policies
  • Studies
    • Blood sodium
    • Emergency procedure in CYP
    • Acute limb ischaemia
    • Acute illness in people with a learning disability
    • Stabilisation of the critically ill child
    • Pleural procedures
  • Publications
    • Reports & related resources
    • Published articles
    • Patient leaflets
    • Other publications
  • Resources
    • Local Reporter and Ambassadors
    • Online Questionnaires
    • Recommendations
    • Frequently Asked Questions
    • Classification of Intervention
    • Grading of Care
    • Surgical Outcome Risk Tool (SORT)
    • Information Governance
    • Useful Links
  • Donate
  • Contact
  • Staff Login
Home/Studies/Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis
This study has been commissioned by Healthcare Quality Improvement Partnership HQIP
as part of the Child Health Clinical Outcome Review Programme as part of the current contract awarded in 2019.
For information on how we use data click here

Data collection for study: Cosed
Patient identification spreadsheet data collection: Closed
Clinical data collection: Closed
Organisational data collection: Closed
Publication date: February 2025

Aim
To review the quality of care in children and young adults (0-24 years) with Juvenile Idiopathic Arthritis (JIA).

Participation
All providers of healthcare across England, Wales and Northern Ireland, where children and young adults with JIA might be cared for. This will include acute, community and independent organisations. Primary care practices will be asked to participate where it is identified that a patient selected for inclusion in the study was under the care of their practice.

Data collection
The timeframe from which data will be sampled will be the 1st April 2021 – 31st March 2023.

Patient identification spreadsheets
Two patient identification spreadsheets will be used to identify children and young adults to include in the study – one to be completed by a study contact and one to be completed by the local reporter.
Study contacts: Please provide the details of the last 50 children and young adults (aged 0-24 years) referred to the rheumatology service, up to the 31st March 2023, and no earlier than the 1st April 2021, where a diagnosis of JIA has been made.
Local reporters: Please provide the details of all children and young adults (0-24 years) who presented to their organisation between 1st April 2021 – 31st March 2023 with at least one of the included ICD10 codes recorded in any position. Please include day case admissions and outpatient attendances where available.

Clinician questionnaires
Clinician questionnaires will be sent for a sample of children and young adults, where the diagnosis was made between the 1st April 2019 – 31st March 2023. Up to 15 patients per hospital will be sampled for inclusion. A questionnaire will be sent to the rheumatologist responsible for the ongoing care of the patient. In addition to this, questionnaires will also be sent if the hospital is identified as providing care to a child or young adult identified for inclusion in the study via another organisation.

Primary care combined clinician and organisational questionnaire
The primary care combined clinician and organisational questionnaire will be sent for all children and young adults sampled for inclusion in the study where the GP can be identified.

Case note extracts for review
Case notes will be requested for all patients included in the peer review aspect of the study.

Organisational questionnaires
An organisational questionnaire will be sent to all providers of healthcare where children and young adults with JIA might be cared for.

Patient Participation
The initial Patient Participation Groups have now finished; however, we will be asking children and young adults with JIA to complete a survey of their experiences.
Please see the study protocol for more detailed information on the study methods.

Any other queries relating to this study should also be addressed to arthritis@ncepod.org.uk .

This page will be updated regularly so please check for further information.


 

Download links
  • Protocol
    • Study contacts: Patient identification spreadsheet
      • Local reporters: Patient identification spreadsheet
        • SNOMED codes for inclusion
          • Study information poster for clinicians
            • Study information poster for young people
              • Study information poster for parent carers
                • Study information poster
                  • Study information poster (easy read version)
                    • FAQs
                      • Clinician Questionnaire
                        • Organisational Questionnaire
                        •  

Ground Floor
Abbey House
74-76 St John Street
London
EC1M 4DZ

Registered Charity Number: 1075588
Registered in England and Wales
A company limited by guarantee
Company Number: 3019382

Get NCEPOD newsletters emailed to you.
Designed by Robert Alleway 2018
Copyright Policy
  • Home Page
  • About
  • Accessibility
  • Disclaimer
  • Sitemap
  • Contact